期刊
BIOTECHNOLOGY AND BIOENGINEERING
卷 110, 期 6, 页码 1550-1564出版社
WILEY
DOI: 10.1002/bit.24885
关键词
glycosylation; glycolipids; glycoproteins; glycome; glycoengineering; glycosyltransferase; oligosaccharyltransferase; lipopolysaccharides; sugar nucleotides; Escherichia coli
资金
- National Science Foundation [CBET-1159581]
- National Institutes of Health [2R44GM088905-02]
- Div Of Chem, Bioeng, Env, & Transp Sys
- Directorate For Engineering [1159581] Funding Source: National Science Foundation
There is an urgent need for new tools that enable better understanding of the structure, recognition, metabolism, and biosynthesis of glycans as well as the production of biologically important glycans and glycoconjugates. With the discovery of glycoprotein synthesis in bacteria and functional transfer of glycosylation pathways between species, Escherichia coli cells have become a tractable host for both understanding glycosylation and the underlying glycan code of living cells as well as for expressing glycoprotein therapeutics and vaccines. Here, we review recent efforts to harness natural biological pathways and engineer synthetic designer pathways in bacteria for making complex glycans and conjugating these to lipids and proteins. The result of these efforts has been a veritable transformation of bacteria into living factories for scalable, bottom-up production of complex glycoconjugates by design. Biotechnol. Bioeng. 2013; 110: 15501564. (c) 2013 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据